11 results
8-K
EX-3.1
TTNP
Titan Pharmaceuticals, Inc. (de)
8 Jan 24
Amendments to Articles of Incorporation or Bylaws
5:13pm
8-K
EX-3.1
TTNP
Titan Pharmaceuticals, Inc. (de)
5 Jul 22
Titan Pharmaceuticals Announces FDA Clearance of IND Application for Nalmefene Implant
5:13pm
8-K
EX-3.1
TTNP
Titan Pharmaceuticals, Inc. (de)
29 Dec 21
Amendments to Articles of Incorporation or Bylaws
6:15am
8-K
EX-3.1
TTNP
Titan Pharmaceuticals, Inc. (de)
1 Dec 20
Titan Pharmaceuticals Announces Reverse Stock Split
4:45pm
8-K
EX-3.1
TTNP
Titan Pharmaceuticals, Inc. (de)
25 Jan 19
Titan Pharmaceuticals Announces Reverse Stock Split
12:00am
8-K
EX-3.1
irmfw
25 Sep 18
Titan Pharmaceuticals Prices $9,500,000 Public Offering
5:13pm
8-K
EX-3.1
lj2wcjpkpw1a0zyp g9
28 Sep 15
Titan Pharmaceuticals Announces Reverse Stock Split
12:00am
8-K
EX-3.1
8255wa y8rtjtf
21 Dec 11
Entry into a Material Definitive Agreement
12:00am
10-12G
EX-3.1
8tuqh
14 Jan 10
Registration of securities
12:00am
- Prev
- 1
- Next